Localization of treatment-resistant areas in patients with psoriasis on biologics.
Kasper Fjellhaugen HjulerLars IversenM K RasmussenK KofoedL SkovC ZachariaePublished in: The British journal of dermatology (2019)
In real-world clinical practice, the most common sites of recalcitrant psoriasis in patients treated with biologic agents are the anterior lower leg, posterior lower leg and elbows. Recalcitrant psoriasis in no specific area caused a greater impact on quality of life than any other area.